Cherry Bekaert’s National Healthcare & Life Sciences Deal Advisory Practice is uniquely positioned at the intersection of our Private Equity and Healthcare & Life Sciences practices. This means your Cherry Bekaert Healthcare & Life Sciences Transactions team not only has extensive deal experience, but also possess in-depth expertise of the healthcare and life sciences segment. As a result, we enhance the efficiency and value of every healthcare transaction at each stage of the deal with our industry-unique 100% healthcare & life sciences/private equity led team!
About Cherry Bekaert’s Deal Advisory Services
Cherry Bekaert’s team of deal advisory professionals has assisted healthcare clients in every aspect of strategic and financial deals from start to finish, including buy-side and sell-side due diligence, pre-deal valuation services and post- deal purchase price allocations, as well as related, tax and valuation services. Our Transactions team has undertaken deals with total transaction values in excess of $126 billion. This established track record combined with the knowledge and expertise gained in middle market transactions makes the Firm an ideal partner for any transaction project.